🇺🇸 FDA
Pipeline program

Association atezolizumab + BDB001 + RT

IB 2019-01

Phase 2 small_molecule active

Quick answer

Association atezolizumab + BDB001 + RT for Solid Tumor, Adult is a Phase 2 program (small_molecule) at Eikon Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
Eikon Therapeutics
Indication
Solid Tumor, Adult
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials